Small-molecule Bcl-2 Antagonists As Targeted Therapy in Oncology

Overview

Journal Curr Oncol

Publisher MDPI

Specialty Oncology

Date 2008 Dec 17

PMID 19079626

Citations 8

Authors

M R Warr

G C Shore

Affiliations

Soon will be listed here.

Abstract

Dynamic protein-protein interactions between proapoptotic and pro-survival Bcl-2 family members regulate outer-mitochondrial membrane permeabilization and cytochrome c release, key events in the path to apoptosis. Their relative levels often dictate the fate of a cell following an apoptotic stimulus. However, in cancer cells, the pro-survival Bcl-2 family members are frequently upregulated, thereby creating a constitutive block to apoptosis and resulting in continued cell survival under conditions that normally result in cell death. Because many chemotherapeutics used to treat cancer also trigger apoptosis, this upregulation of pro-survival members also contributes to resistance to conventional cancer therapies. Strategies that inactivate pro-survival Bcl-2 family members therefore suggest a means by which this downstream block in apoptosis can be alleviated, resulting in the selective killing of malignant cells. Here, we outline the progress of three small-molecule Bcl-2 antagonists that have advanced into clinical evaluation.

Citing Articles

Targeting apoptosis in cancer therapy.

Carneiro B, El-Deiry W Nat Rev Clin Oncol. 2020; 17(7):395-417.

PMID: 32203277 PMC: 8211386. DOI: 10.1038/s41571-020-0341-y.

Effect of SP600125 on the mitotic spindle in HeLa Cells, leading to mitotic arrest, endoreduplication and apoptosis.

Mili D, Abid K, Rjiba I, Kenani A Mol Cytogenet. 2016; 9:86.

PMID: 27924151 PMC: 5123282. DOI: 10.1186/s13039-016-0296-y.

Comparison of in vitro antileukemic activity of obatoclax and ABT-737.

Opydo-Chanek M, Mazur L Tumour Biol. 2016; 37(8):10839-49.

PMID: 26880588 PMC: 4999481. DOI: 10.1007/s13277-016-4943-z.

The novel BH-3 mimetic apogossypolone induces Beclin-1- and ROS-mediated autophagy in human hepatocellular carcinoma [corrected] cells.

Cheng P, Ni Z, Dai X, Wang B, Ding W, Rae Smith A Cell Death Dis. 2013; 4:e489.

PMID: 23392177 PMC: 3734844. DOI: 10.1038/cddis.2013.17.

Distinct regulation of cytoplasmic calcium signals and cell death pathways by different plasma membrane calcium ATPase isoforms in MDA-MB-231 breast cancer cells.

Curry M, Luk N, Kenny P, Roberts-Thomson S, Monteith G J Biol Chem. 2012; 287(34):28598-608.

PMID: 22733819 PMC: 3436507. DOI: 10.1074/jbc.M112.364737.

References

Huang D, Strasser A . BH3-Only proteins-essential initiators of apoptotic cell death. Cell. 2001; 103(6):839-42. DOI: 10.1016/s0092-8674(00)00187-2. View

Zhang M, Liu H, Guo R, Ling Y, Wu X, Li B . Molecular mechanism of gossypol-induced cell growth inhibition and cell death of HT-29 human colon carcinoma cells. Biochem Pharmacol. 2003; 66(1):93-103. DOI: 10.1016/s0006-2952(03)00248-x. View

Li J, Viallet J, Haura E . A small molecule pan-Bcl-2 family inhibitor, GX15-070, induces apoptosis and enhances cisplatin-induced apoptosis in non-small cell lung cancer cells. Cancer Chemother Pharmacol. 2007; 61(3):525-34. DOI: 10.1007/s00280-007-0499-3. View

Kim H, Rafiuddin-Shah M, Tu H, Jeffers J, Zambetti G, Hsieh J . Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies. Nat Cell Biol. 2006; 8(12):1348-58. DOI: 10.1038/ncb1499. View

Konopleva M, Watt J, Contractor R, Tsao T, Harris D, Estrov Z . Mechanisms of antileukemic activity of the novel Bcl-2 homology domain-3 mimetic GX15-070 (obatoclax). Cancer Res. 2008; 68(9):3413-20. PMC: 4096127. DOI: 10.1158/0008-5472.CAN-07-1919. View

Kline M, Rajkumar S, Timm M, Kimlinger T, Haug J, Lust J . R-(-)-gossypol (AT-101) activates programmed cell death in multiple myeloma cells. Exp Hematol. 2008; 36(5):568-76. PMC: 3904353. DOI: 10.1016/j.exphem.2008.01.003. View

Hanahan D, Weinberg R . The hallmarks of cancer. Cell. 2000; 100(1):57-70. DOI: 10.1016/s0092-8674(00)81683-9. View

Muchmore S, Sattler M, Liang H, Meadows R, Harlan J, Yoon H . X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature. 1996; 381(6580):335-41. DOI: 10.1038/381335a0. View

Wang G, Nikolovska-Coleska Z, Yang C, Wang R, Tang G, Guo J . Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins. J Med Chem. 2006; 49(21):6139-42. DOI: 10.1021/jm060460o. View

10.

Gross A, McDonnell J, Korsmeyer S . BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 1999; 13(15):1899-911. DOI: 10.1101/gad.13.15.1899. View

11.

Tahir S, Yang X, Anderson M, Morgan-Lappe S, Sarthy A, Chen J . Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737. Cancer Res. 2007; 67(3):1176-83. DOI: 10.1158/0008-5472.CAN-06-2203. View

12.

Chen L, Willis S, Wei A, Smith B, Fletcher J, Hinds M . Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell. 2005; 17(3):393-403. DOI: 10.1016/j.molcel.2004.12.030. View

13.

Balakrishnan K, Wierda W, Keating M, Gandhi V . Gossypol, a BH3 mimetic, induces apoptosis in chronic lymphocytic leukemia cells. Blood. 2008; 112(5):1971-80. PMC: 2518898. DOI: 10.1182/blood-2007-12-126946. View

14.

Oltersdorf T, Elmore S, Shoemaker A, Armstrong R, Augeri D, Belli B . An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature. 2005; 435(7042):677-81. DOI: 10.1038/nature03579. View

15.

Reed J, Pellecchia M . Apoptosis-based therapies for hematologic malignancies. Blood. 2005; 106(2):408-18. DOI: 10.1182/blood-2004-07-2761. View

16.

Adams J, Cory S . The Bcl-2 protein family: arbiters of cell survival. Science. 1998; 281(5381):1322-6. DOI: 10.1126/science.281.5381.1322. View

17.

Chen S, Dai Y, Harada H, Dent P, Grant S . Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing Bak activation and Bax translocation. Cancer Res. 2007; 67(2):782-91. DOI: 10.1158/0008-5472.CAN-06-3964. View

18.

Wei M, Zong W, Cheng E, LINDSTEN T, Panoutsakopoulou V, Ross A . Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science. 2001; 292(5517):727-30. PMC: 3049805. DOI: 10.1126/science.1059108. View

19.

Letai A, Bassik M, Walensky L, Sorcinelli M, Weiler S, Korsmeyer S . Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell. 2002; 2(3):183-92. DOI: 10.1016/s1535-6108(02)00127-7. View

20.

Meng Y, Tang W, Dai Y, Wu X, Liu M, Ji Q . Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa. Mol Cancer Ther. 2008; 7(7):2192-202. PMC: 2515935. DOI: 10.1158/1535-7163.MCT-08-0333. View